Mesotherapy

Dr. Sarah Chen
PhD, Molecular Biology
Mesotherapy is a minimally invasive medical technique that involves delivering microinjections of pharmacologically active substances directly into the mesoderm β the middle layer of the skin corresponding to the dermis and superficial subcutaneous tissue [2]. By placing therapeutic agents precisely where they are needed, mesotherapy bypasses the barrier function of the epidermis and achieves higher local concentrations than topical application could ever deliver. Today, PDRN mesotherapy is one of the most popular forms of this technique in aesthetic dermatology worldwide [4].
Historical Origins
Mesotherapy was developed in 1952 by Dr. Michel Pistor, a French physician practicing in Bray-et-LΓ», a small village north of Paris [1][2]. Pistor initially used intradermal injections of procaine to treat a range of conditions, from local pain to vascular disorders. He coined the term "mesotherapy" from the Greek "meso" (middle) and "therapeia" (treatment), reflecting the technique's focus on treating tissues derived from the embryonic mesoderm [2].
Pistor formalized his observations into a treatment philosophy summarized by his famous dictum: "little, rarely, and in the right place" (peu, rarement, au bon endroit) [2][3]. This principle β minimal doses delivered infrequently but precisely β remains the foundation of modern mesotherapy practice. The French Academy of Medicine officially recognized mesotherapy as a specialty in 1987, and it has since spread to clinical practice across Europe, Asia, and the Americas [2].
How Mesotherapy Works
The fundamental principle of mesotherapy is that direct intradermal delivery of active substances achieves therapeutic concentrations at the target tissue while minimizing systemic exposure [2][3]. When a substance is injected into the dermis, it creates a local depot that slowly diffuses through surrounding tissue, providing sustained exposure to the active ingredient.
Injection Depth
Mesotherapy injections are typically administered at depths ranging from 0.5 mm to 4 mm, depending on the treatment area and objective [3][5]:
- Epidermal injection (0.5β1 mm) β Superficial nappage technique, creating tiny wheals at the epidermal-dermal junction. Used for delivering hydrating and revitalizing cocktails over large surface areas.
- Superficial dermal injection (1β2 mm) β Targets the papillary dermis where the highest density of fibroblasts and capillaries reside. This is the most common depth for PDRN skin boosters and biorevitalization treatments.
- Deep dermal injection (2β4 mm) β Reaches the reticular dermis and superficial subcutaneous tissue. Used for treating deeper wrinkles, scars, and targeted fat reduction (lipolysis cocktails).
Injection Techniques
Several standardized injection techniques are used in mesotherapy [2][3]:
- Nappage β Rapid, superficial point-by-point injections covering a broad treatment area. Each injection delivers a tiny volume (0.01β0.05 mL) at a depth of approximately 1β2 mm. This is the most common technique for facial skin rejuvenation with PDRN products.
- Point-by-point (papule technique) β Individual injections placed at specific points, each creating a small visible papule of product in the dermis. Used for targeted treatment of wrinkles, scars, or specific concern areas.
- Linear threading β The needle is inserted and advanced horizontally within the dermis while product is deposited along the track. Used for treating individual wrinkles or folds.
- Mesoperfusion β Slow infusion via a short needle or cannula. Less commonly used for aesthetic applications.
Needle Specifications
Modern mesotherapy for aesthetic purposes typically employs 30G to 33G needles, with 32G being the most common for PDRN injections [3][5]. The ultra-fine gauge minimizes tissue trauma, bruising risk, and patient discomfort. Some practitioners use multi-needle systems (mesogun or mesotherapy pistol) that deliver multiple simultaneous injections with precisely controlled depth and volume, improving treatment uniformity and reducing procedure time [3].
PDRN Mesotherapy
PDRN mesotherapy has become one of the most popular applications of the mesotherapy technique in modern aesthetic medicine [4]. Products such as Rejuran Healer, Nucleofill, and Plinest are specifically formulated for intradermal delivery via mesotherapy technique.
Why Mesotherapy Is Ideal for PDRN
PDRN molecules (polydeoxyribonucleotide chains of 50β2000 kDa) are too large to penetrate the skin's barrier through topical application alone. Mesotherapy solves this problem by placing PDRN directly into the dermis, where it can [4]:
- Bind to adenosine A2A receptors on fibroblasts, activating the cAMP-PKA-CREB signaling cascade that stimulates collagen gene transcription.
- Enter the nucleotide salvage pathway β PDRN fragments are broken down by nucleases into individual nucleosides and nucleotides that cells use as building blocks for DNA repair and cell proliferation.
- Create a sustained-release depot β The viscosity of PDRN gel solutions allows them to remain in the dermal tissue for days to weeks, providing prolonged biological activity.
Treatment Protocol
A standard PDRN mesotherapy protocol typically consists of [4][5]:
- Treatment area preparation β Cleansing and optional topical anesthetic (lidocaine cream, 20β30 minutes prior).
- Injection volume β 2β3 mL of PDRN product distributed across the treatment area.
- Injection technique β Nappage technique with 0.02β0.05 mL per injection point, spaced 5β10 mm apart.
- Injection depth β 1β2 mm into the superficial to mid-dermis.
- Treatment frequency β 3β5 sessions spaced 2β4 weeks apart for the initial course, followed by maintenance sessions every 1β3 months.
Treatment Areas
Mesotherapy is versatile and can be applied to virtually any body area where intradermal delivery is desired [2][3][5]:
- Face β The most common treatment area for PDRN mesotherapy. Addresses fine lines, skin texture, hydration, and overall skin quality. The full face is treated using nappage technique.
- Neck β Horizontal neck lines (necklace lines) and crepey skin respond well to mesotherapy-delivered PDRN. The thinner neck skin requires careful depth control.
- DΓ©colletage β Sun-damaged chest skin with crepiness and photodamage benefits from PDRN mesotherapy for texture and tone improvement.
- Hands β The dorsal hands show early signs of aging due to thin skin and UV exposure. Mesotherapy restores volume cues and improves skin quality.
- Under-eye area β Specialized PDRN products (e.g., Rejuran I) delivered via careful mesotherapy technique improve dark circles, fine lines, and skin thinning.
- Scalp β PDRN mesotherapy for hair follicle stimulation is an emerging application for androgenetic alopecia.
Expected Results
Clinical studies evaluating mesotherapy-delivered PDRN report consistent improvements across multiple skin quality parameters [4][5]:
- Skin elasticity β Measurable improvement in Cutometer readings after 3β4 sessions, reflecting increased dermal collagen and elastin.
- Hydration β Corneometer values increase significantly, indicating improved water-holding capacity of the dermis.
- Surface texture β Visioscan analysis shows reduced roughness parameters and improved skin smoothness.
- Histological changes β Punch biopsies reveal increased fibroblast density, higher collagen content, and improved organization of dermal extracellular matrix.
Results are cumulative, with the most significant improvements appearing 4β8 weeks after the final treatment session as collagen remodeling matures [4][5].
Safety Profile
Mesotherapy has a well-established safety profile when performed by trained practitioners using sterile technique and approved products [2][3]:
Common Side Effects
- Transient erythema (redness) at injection sites β resolves within 24β48 hours
- Mild swelling or papules at injection points β typically resolves within 24β72 hours
- Minor bruising β may occur, especially in patients on anticoagulants; resolves within 5β7 days
- Temporary injection-site tenderness
Rare Complications
- Infection (minimized with proper aseptic technique)
- Allergic reaction to injected substances (extremely rare with PDRN due to its high biocompatibility)
- Granuloma formation (reported with some non-PDRN mesotherapy cocktails)
- Post-inflammatory hyperpigmentation (rare, more common in darker skin types)
Contraindications
Mesotherapy should be avoided in patients with active skin infection at the treatment site, known allergy to the injected substance, bleeding disorders, pregnancy, or immunosuppression [2][3]. Patients should discontinue anticoagulant medications as directed by their physician prior to treatment.
Mesotherapy vs. Other Delivery Methods
| Feature | Mesotherapy | Topical Application | Microneedling | Laser-Assisted Delivery |
|---------|-------------|--------------------|--------------|-----------------------|
| Depth control | Precise, adjustable | Surface only | Variable (0.25β2.5 mm) | Variable |
| PDRN bioavailability | High (direct dermal) | Low (<5%) | Moderate | Moderate |
| Practitioner requirement | Medical professional | Self-application | Varies | Medical professional |
| Downtime | Minimal (24β48 h) | None | 24β72 h | Variable |
| Cost per session | ModerateβHigh | Low | LowβModerate | High |
Mesotherapy remains the gold standard for delivering PDRN in clinical settings because it provides the most precise depth control and highest local bioavailability of any delivery method [2][4]. For patients who prefer at-home treatments, topical PDRN serums offer a complementary maintenance option between mesotherapy sessions.
References
- [1]Pistor M. What is mesotherapy?. Le Chirurgien-Dentiste de France. 1976;46(288):59-60. doi:10.1007/s004310050633
- [2]Mammucari M, Gatti A, Esposito S, Muscianese MA, Ronconi G, Nori SL, Maggiori E, Rocchi R. Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects. Scientific World Journal. 2014;2014:842645. doi:10.1155/2014/842645 PMID:25587580
- [3]Herreros FOC, Moraes AM, Velho PENF. Mesotherapy: a bibliographical review. Anais Brasileiros de Dermatologia. 2011;86(1):96-101. doi:10.1590/S0365-05962011000100013 PMID:21437529
- [4]Squadrito F, Bitto A, Irrera N, Pizzino G, Pallio G, Minutoli L, Altavilla D. Pharmacological Activity and Clinical Use of PDRN. Current Pharmaceutical Design. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [5]Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatologic Surgery. 2006;32(12):1467-1472. doi:10.1111/j.1524-4725.2006.32354.x PMID:17199651